Baxter International | BAX - Market Capitalization



Baxter International reported $12.4B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Abbott USD 236.64B 6.58B Jun/2025
AtriCure USD 1.62B 25M Jun/2025
Avanos Medical USD 566M 93M Jun/2025
Baxter International USD 15.54B 2.02B Jun/2025
Becton, Dickinson and Co. USD 49.37B 16.28B Jun/2025
Boston Scientific USD 158.91B 9.7B Jun/2025
Cooper Companies USD 13.45B 649M Sep/2025
Dexcom USD 34.23B 7.45B Jun/2025
Edwards Lifesciences USD 45.88B 3.27B Jun/2025
Fresenius EUR 24.04B 1.84B Jun/2025
Globus Medical USD 7.99B 1.92B Jun/2025
Halozyme Therapeutics USD 6.41B 1.47B Jun/2025
ICU Medical USD 3.25B 164M Jun/2025
Insulet USD 22.11B 3.63B Jun/2025
Integra LifeSciences USD 954M 745M Jun/2025
Intuitive Surgical USD 194.77B 17.33B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
Laboratory Of America USD 21.97B 2.5B Jun/2025
Masimo USD 9.12B 118M Jun/2025
Merit Medical Systems USD 5.52B 724M Jun/2025
Quest Diagnostics USD 20.05B 1.17B Jun/2025
Smith & Nephew GBP 13.32B 4.65B Jun/2025
Stryker USD 151.2B 8.94B Jun/2025
Tandem Diabetes Care USD 1.24B 33M Jun/2025
Teleflex USD 5.23B 940M Jun/2025
Terumo JPY 3.92T 221.51B Jun/2025
Zimmer Biomet Holdings USD 18.05B 4.35B Jun/2025